#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Breast cancer metastatic Chronic cutaneous lupus erythematosus Chronic lymphocytic leukaemia recurrent Krabbe's disease Testicular leiomyosarcoma Autoimmune disorder Chronic hepatitis B Antiphospholipid syndrome Ovarian cancer Epilepsy Alpha-1 antitrypsin deficiency Eosinophilic granulomatosis with polyangiitis Human papilloma virus immunisation Neuroendocrine tumour Kidney transplant rejection More trials…

    Learn about Rare Diseases

    Marfan’s syndrome – Life with Disease Congenital hypotransferrinaemia – Trials in Disease Sarcoidosis – Basic Information Factor VIII deficiency – Life with Disease Hereditary hypophosphataemic rickets – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Congenital hypotransferrinaemia Turner’s syndrome – Basic Information Haemolytic uraemic syndrome – Diagnostics Shprintzen-Goldberg syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dinutuximab Beta Anhydrous Caffeine Valganciclovir Hydrochloride Bms-986442 Kk8123 A/(H3N2)-LIKE VIRUS ANTIGEN Citicoline Sodium Etrinabdione Venglustat INF904 Paclitaxel Encaleret Sulfate Ecoo15 Aluminium Leriglitazone Florbetapir (18F) Farletuzumab Ecteribulin Valganciclovir ALENDRONATE SODIUM TRIHYDRATE ISPAGHULA HUSK More therapies…

    Learn about Your Condition

    Bladder cancer stage III Fragile X syndrome Cortical dysplasia Autoimmune hepatitis Critical illness Liposarcoma metastatic Renal cancer recurrent Renal injury Myocarditis post infection H1N1 influenza Schizophreniform disorder Myxofibrosarcoma Marfan's syndrome Renal cancer stage IV Langerhans' cell histiocytosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • BLEXIMENIB
    • Azacitidine
    • Venetoclax
    Austria Belgium Czechia Denmark France Germany +6

  • Study on Tebentafusp and Liver Radiotherapy for Patients with Metastatic Uveal Melanoma HLA A*02:01 Positive

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Tebentafusp
    Italy

  • Evaluation of SB-007 Safety and Efficacy in Patients with Stargardt Disease Type 1 (STGD1) Caused by ABCA4 Gene Mutations

    Recruiting

    2 1 1
    Investigated Drugs:
    • ADENO-ASSOCIATED VIRUS VECTOR SEROTYPE 8 ENCODING THE ABCA4 PROTEIN, C-REGION
    • ADENO-ASSOCIATED VIRUS VECTOR SEROTYPE 8 ENCODING THE ABCA4 PROTEIN, N-REGION
    Belgium Germany

  • Study of mRNA-4157 and Pembrolizumab for Patients with Metastatic Melanoma

    Recruiting

    2 1 1
    Investigated Drugs:
    • Mrna-4157
    • Pembrolizumab
    France Germany Greece Italy Poland Portugal +1

  • Evaluation of Hydrocortisone, Octreotide, and Teres Ligament Patch Combination to Prevent Complications After Pancreatoduodenectomy in Patients with Pancreatic Head Cancer or IPMN

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Octreotide Acetate
    • Hydrocortisone
    Belgium Denmark Finland Italy The Netherlands Norway +1

  • Study Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly Patients or Those at Risk of Bleeding After Balloon Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    Belgium Italy Luxembourg Spain
Previous Page
1 … 170 171 172 173 174 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!